Popvax Blog company blog

PVX-001: open-source Covid-19 vaccine starts Phase 1 trial

First participants safely dosed in Melbourne, Australia, on August 31, 2026, in the first-in-human trial of our broadly-protective COVID-19 vaccine candidate PVX-001.
Points
143
HN comments
32
Submissions
1
Cited by
0 commenters

Science & SpaceTech Industry & Business2026

On Hacker News

SubmittedTitle on HNPointsComments
Oct 10, 2026PVX-001: open-source Covid-19 vaccine starts Phase 1 trial by jajoosam14332

Related posts from the same era